These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 8649569)

  • 1. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group.
    Privitera M; Fincham R; Penry J; Reife R; Kramer L; Pledger G; Karim R
    Neurology; 1996 Jun; 46(6):1678-83. PubMed ID: 8649569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group.
    Faught E; Wilder BJ; Ramsay RE; Reife RA; Kramer LD; Pledger GW; Karim RM
    Neurology; 1996 Jun; 46(6):1684-90. PubMed ID: 8649570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pooled analysis of adjunctive topiramate in refractory partial epilepsy.
    Peeters K; Adriaenssen I; Wapenaar R; Neto W; Pledger G
    Acta Neurol Scand; 2003 Jul; 108(1):9-15. PubMed ID: 12807387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures.
    Ben-Menachem E; Henriksen O; Dam M; Mikkelsen M; Schmidt D; Reid S; Reife R; Kramer L; Pledger G; Karim R
    Epilepsia; 1996 Jun; 37(6):539-43. PubMed ID: 8641230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy.
    Tassinari CA; Michelucci R; Chauvel P; Chodkiewicz J; Shorvon S; Henriksen O; Dam M; Reife R; Pledger G; Karim R
    Epilepsia; 1996 Aug; 37(8):763-8. PubMed ID: 8764816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy.
    Sharief M; Viteri C; Ben-Menachem E; Weber M; Reife R; Pledger G; Karim R
    Epilepsy Res; 1996 Nov; 25(3):217-24. PubMed ID: 8956919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate in medically intractable partial epilepsies: double-blind placebo-controlled randomized parallel group trial. Korean Topiramate Study Group.
    Epilepsia; 1999 Dec; 40(12):1767-74. PubMed ID: 10612342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of topiramate as adjunctive therapy in refractory partial seizures: United States trial experience.
    Faught E
    Epilepsia; 1997; 38 Suppl 1():S24-7. PubMed ID: 9092954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of topiramate as add-on therapy in refractory partial epilepsy: the European experience.
    Ben-Menachem E
    Epilepsia; 1997; 38 Suppl 1():S28-30. PubMed ID: 9092955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group.
    Elterman RD; Glauser TA; Wyllie E; Reife R; Wu SC; Pledger G
    Neurology; 1999 Apr; 52(7):1338-44. PubMed ID: 10227615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
    Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose topiramate in adults with treatment-resistant partial-onset seizures.
    Guberman A; Neto W; Gassmann-Mayer C;
    Acta Neurol Scand; 2002 Oct; 106(4):183-9. PubMed ID: 12225311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term safety and sustained efficacy of USL255 (topiramate extended-release capsules) in patients with refractory partial-onset seizures.
    Chung SS; Hogan RE; Blatt I; Lawson P B; Nguyen H; Clark AM; Anders B; Halvorsen MB;
    Epilepsy Behav; 2016 Jun; 59():13-20. PubMed ID: 27084978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of adjunctive topiramate therapy in infants with refractory partial seizures.
    Novotny E; Renfroe B; Yardi N; Nordli D; Ness S; Wang S; Weber T; Kurland CL; Yuen E; Eerdekens M; Venkatraman L; Nye JS; Ford L
    Neurology; 2010 Mar; 74(9):714-20. PubMed ID: 20089937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topiramate in the long-term management of refractory epilepsy. Topiramate YOL Study Group.
    Abou-Khalil B
    Epilepsia; 2000; 41(S1):72-6. PubMed ID: 10768305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy.
    Gilliam FG; Veloso F; Bomhof MA; Gazda SK; Biton V; Ter Bruggen JP; Neto W; Bailey C; Pledger G; Wu SC
    Neurology; 2003 Jan; 60(2):196-202. PubMed ID: 12552030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, placebo-controlled study of topiramate in adult patients with refractory partial epilepsy.
    Yen DJ; Yu HY; Guo YC; Chen C; Yiu CH; Su MS
    Epilepsia; 2000 Sep; 41(9):1162-6. PubMed ID: 10999555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topiramate as an adjunctive treatment for refractory partial epilepsy in the elderly.
    Zhang L; Huang J; Zhuang JH; Huang LQ; Zhao ZX
    J Int Med Res; 2011; 39(2):408-15. PubMed ID: 21672344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.